Skip to content
Ep. 119 - Bio€quity Recap, Part 2 episode artwork

May 19, 2022 20 min

Ep. 119 - Bio€quity Recap, Part 2

from BioCentury This Week Hosted by BioCentury

Ensuring that a biotech reaches its key inflection points as effectively as possible during the ongoing capital crunch affects a company across the board, including its people, pipeline and financing toolkit, Shorla’s Sharon Cunningham said on a special Bio€quity Europe edition of the BioCentury This Week podcast. Cunningham and BII’s Bobby Soni joined the BioCentury podcast team to discuss navigating the downturn as a CEO of a private biotech, the untapped talent pools able to run start-ups and the ecosystem in Bio€quity Europe’s next site, Ireland. This week’s podcast is sponsored by MSD (Merck & Co. Inc. in the U.S.). For more information visit, msd.com/licensing. Reach us by sending a text

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Ep. 119 - Bio€quity Recap, Part 2

0:00 20:06

Chapters

  1. 0:33 Brought to you by MSD
  2. 1:20 Introducing Shorla's Sharon Cunningham & BII's Bobby G. Soni
  3. 3:00 A CEO Navigates the Downturn
  4. 9:00 Turning Talent Headwinds into Tailwinds
  5. 15:20 Next Year, in Ireland

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of BioCentury This Week?

This episode is 20 minutes long.

When was this BioCentury This Week episode published?

This episode was published on May 19, 2022.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.